These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 15476293)

  • 1. Low-mode docking search in iGluR homology models implicates three residues in the control of ligand selectivity.
    Rodriguez J; Carcache L; Rein KS
    J Mol Recognit; 2005; 18(2):183-9. PubMed ID: 15476293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subtype selectivity and flexibility of ionotropic glutamate receptors upon antagonist ligand binding.
    Pentikäinen U; Settimo L; Johnson MS; Pentikäinen OT
    Org Biomol Chem; 2006 Mar; 4(6):1058-70. PubMed ID: 16525550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal structures of the GluR5 and GluR6 ligand binding cores: molecular mechanisms underlying kainate receptor selectivity.
    Mayer ML
    Neuron; 2005 Feb; 45(4):539-52. PubMed ID: 15721240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of AMPA and kainate glutamate receptors impairs the viability of oligodendrocytes in vitro.
    Sanchez-Gomez MV; Matute C
    Int J Dev Biol; 1996; Suppl 1():187S-188S. PubMed ID: 9087754
    [No Abstract]   [Full Text] [Related]  

  • 5. (S)-2-Amino-3-(3-hydroxy-7,8-dihydro-6H-cyclohepta[d]isoxazol-4-yl)propionic acid, a potent and selective agonist at the GluR5 subtype of ionotropic glutamate receptors. Synthesis, modeling, and molecular pharmacology.
    Brehm L; Greenwood JR; Hansen KB; Nielsen B; Egebjerg J; Stensbøl TB; Bräuner-Osborne H; Sløk FA; Kronborg TT; Krogsgaard-Larsen P
    J Med Chem; 2003 Apr; 46(8):1350-8. PubMed ID: 12672235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ligand-binding characteristics and related structural features of the expressed goldfish kainate receptors: identification of a conserved disulfide bond and three residues important for ligand binding.
    Wo ZG; Oswald RE
    Mol Pharmacol; 1996 Oct; 50(4):770-80. PubMed ID: 8863821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective agonist binding of (S)-2-amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)propionic acid (AMPA) and 2S-(2alpha,3beta,4beta)-2-carboxy-4-(1-methylethenyl)-3-pyrrolidineacetic acid (kainate) receptors: a molecular modeling study.
    Pentikäinen OT; Settimo L; Keinänen K; Johnson MS
    Biochem Pharmacol; 2003 Dec; 66(12):2413-25. PubMed ID: 14637199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. (2S,4R)-4-methylglutamic acid (SYM 2081): a selective, high-affinity ligand for kainate receptors.
    Zhou LM; Gu ZQ; Costa AM; Yamada KA; Mansson PE; Giordano T; Skolnick P; Jones KA
    J Pharmacol Exp Ther; 1997 Jan; 280(1):422-7. PubMed ID: 8996224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure of a glutamate-receptor ligand-binding core in complex with kainate.
    Armstrong N; Sun Y; Chen GQ; Gouaux E
    Nature; 1998 Oct; 395(6705):913-7. PubMed ID: 9804426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereostructure-activity studies on agonists at the AMPA and kainate subtypes of ionotropic glutamate receptors.
    Johansen TN; Greenwood JR; Frydenvang K; Madsen U; Krogsgaard-Larsen P
    Chirality; 2003 Feb; 15(2):167-79. PubMed ID: 12520509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal structure of the kainate receptor GluR5 ligand-binding core in complex with (S)-glutamate.
    Naur P; Vestergaard B; Skov LK; Egebjerg J; Gajhede M; Kastrup JS
    FEBS Lett; 2005 Feb; 579(5):1154-60. PubMed ID: 15710405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probing the function, conformational plasticity, and dimer-dimer contacts of the GluR2 ligand-binding core: studies of 5-substituted willardiines and GluR2 S1S2 in the crystal.
    Jin R; Gouaux E
    Biochemistry; 2003 May; 42(18):5201-13. PubMed ID: 12731861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereochemistry of glutamate receptor agonist efficacy: engineering a dual-specificity AMPA/kainate receptor.
    Madden DR; Cheng Q; Thiran S; Rajan S; Rigo F; Keinänen K; Reinelt S; Zimmermann H; Jayaraman V
    Biochemistry; 2004 Dec; 43(50):15838-44. PubMed ID: 15595838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kainate receptor agonists and antagonists mediate tolerance to kainic acid and reduce high-affinity GTPase activity in young, but not aged, rat hippocampus.
    Hesp BR; Wrightson T; Mullaney I; Kerr DS
    J Neurochem; 2004 Jul; 90(1):70-9. PubMed ID: 15198668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3-Substituted phenylalanines as selective AMPA- and kainate receptor ligands.
    Szymańska E; Pickering DS; Nielsen B; Johansen TN
    Bioorg Med Chem; 2009 Sep; 17(17):6390-401. PubMed ID: 19656686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of the receptor conformation for iGluR2 agonist binding: QM/MM docking to an extensive conformational ensemble generated using normal mode analysis.
    Sander T; Liljefors T; Balle T
    J Mol Graph Model; 2008 Jun; 26(8):1259-68. PubMed ID: 18203639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tyr702 is an important determinant of agonist binding and domain closure of the ligand-binding core of GluR2.
    Frandsen A; Pickering DS; Vestergaard B; Kasper C; Nielsen BB; Greenwood JR; Campiani G; Fattorusso C; Gajhede M; Schousboe A; Kastrup JS
    Mol Pharmacol; 2005 Mar; 67(3):703-13. PubMed ID: 15591246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heteroaryl analogues of AMPA. Synthesis and quantitative structure-activity relationships.
    Bang-Andersen B; Lenz SM; Skjaerbaek N; Søby KK; Hansen HO; Ebert B; Bøgesø KP; Krogsgaard-Larsen P
    J Med Chem; 1997 Aug; 40(18):2831-42. PubMed ID: 9288165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AMPA and kainate receptors each mediate excitotoxicity in oligodendroglial cultures.
    Sánchez-Gómez MV; Matute C
    Neurobiol Dis; 1999 Dec; 6(6):475-85. PubMed ID: 10600403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structures of the ligand-binding core of iGluR2 in complex with the agonists (R)- and (S)-2-amino-3-(4-hydroxy-1,2,5-thiadiazol-3-yl)propionic acid explain their unusual equipotency.
    Beich-Frandsen M; Pickering DS; Mirza O; Johansen TN; Greenwood J; Vestergaard B; Schousboe A; Gajhede M; Liljefors T; Kastrup JS
    J Med Chem; 2008 Mar; 51(5):1459-63. PubMed ID: 18269227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.